colonbroom glp-1 booster Review: A Doctor's Honest Opinion Think of ColonBroom's GLP-1 Booster

Microdosing lowers medication exposure while the same receptor pathways remain active

Finally, a pooled analysis of RCTs and open-label phase III studies showed that once-weekly exenatide reduced albuminuria 26% (95% CI%: 39.5 to 10%) compared with comparators (Van Der Aart-Van Der Beek et al., 2020)

Lin, C.M., et al., Unexpected cardiovascular risks of glucagon-like peptide-1 receptor agonist and aspirin co-administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study

Some people notice their weight dropping quickly in the first few weeks due to weight loss and appetite reduction, but its important to maintain realistic expectations on average, you will see around 1 to 2 pounds of weight loss per week after the initial phase

doi: 10.1053/j.ackd.2014.11.004 38 MatsusakaTNiimuraFShimizuAPastanISaitoAKoboriHet al

These benefits can be partly attributed to weight loss and reduced insulin resistance through GLP-1 use as this helps reduce insulin-driven androgen excess and restore regular ovulation 13